1. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial. Issue 5 (May 2021) Authors: Andre, Thierry; Amonkar, Mayur; Norquist, Josephine M; Shiu, Kai-Keen; Kim, Tae Won; Jensen, Benny Vittrup; Jensen, Lars Henrik; Punt, Cornelis J A; Smith, Denis; Garcia-Carbonero, Rocio; Sevilla, Isabel; De La Fouchardiere, Christelle; Rivera, Fernando; Elez, Elena; Diaz, Luis A; Yoshino, Takayu... Journal: Lancet oncology Issue: Volume 22:Issue 5(2021) Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗